Poseida Therapeutics, Inc.

📍 San Diego, United States🗓 Founded 2014👥 322 employees💰 Last funded Jul 2021
Biotechnology Research🌐 poseida.com
Website LinkedIn
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company’s pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. Poseida’s approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral Super piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies. The Company has formed global strategic collaborations with Roche and Takeda to unlock the promise of cell and gene therapies for patients. Learn more at www.poseida.com.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Poseida Therapeutics, Inc.?
Poseida Therapeutics, Inc. has 1 investors on record on gritt.io and 1 late-stage investors.
When did Poseida Therapeutics, Inc. last raise funding?
The most recent investment in Poseida Therapeutics, Inc. recorded on gritt.io was in July 2021.
When was Poseida Therapeutics, Inc. founded?
Poseida Therapeutics, Inc. was founded in 2014.
What industry is Poseida Therapeutics, Inc. in?
Poseida Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Poseida Therapeutics, Inc. based?
Poseida Therapeutics, Inc. is headquartered in San Diego, United States.